Simplex Trading’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,071
| Closed | -$38.1K | – | 8440 |
|
|
2024
Q3 | $51K | Buy |
+6,071
| New | +$35.8K | ﹤0.01% | 5852 |
|
|
2024
Q1 | – | Sell |
-71,991
| Closed | -$323K | – | 8784 |
|
|
2023
Q4 | $241K | Buy |
+71,991
| New | +$179K | ﹤0.01% | 4477 |
|
|
2023
Q3 | – | Sell |
-2,379
| Closed | -$3.92K | – | 8586 |
|
|
2023
Q2 | $3K | Buy |
2,379
+2,243
| +1,649% | +$2.98K | ﹤0.01% | 8169 |
|
|
2023
Q1 | $0 | Buy |
+136
| New | +$134 | ﹤0.01% | 8939 |
|
|
2022
Q3 | – | Sell |
-7,105
| Closed | -$8.52K | – | 9834 |
|
|
2022
Q2 | $6K | Sell |
7,105
-929
| -12% | -$1.52K | ﹤0.01% | 8688 |
|
|
2022
Q1 | $16K | Buy |
8,034
+2,606
| +48% | +$6.98K | ﹤0.01% | 8439 |
|
|
2021
Q4 | $48K | Sell |
5,428
-14,916
| -73% | -$196K | ﹤0.01% | 7309 |
|
|
2021
Q3 | $438K | Buy |
20,344
+200
| +1% | +$3.45K | ﹤0.01% | 4297 |
|
|
2021
Q2 | $418K | Buy |
20,144
+11,279
| +127% | +$214K | ﹤0.01% | 4437 |
|
|
2021
Q1 | $166K | Sell |
8,865
-27,457
| -76% | -$592K | ﹤0.01% | 5032 |
|
|
2020
Q4 | $799K | Buy |
+36,322
| New | +$756K | ﹤0.01% | 2837 |
|
Simplex Trading's APLT Position: Q4 2024 in Review
Simplex Trading sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 6,071 shares — an estimated $38.1K sold.
Simplex Trading first reported a position in APLT in Q4 2020 and held it in 11 quarters. The position peaked at $799K in Q4 2020. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.
- Simplex Trading reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
- Simplex Trading sold 6,071 Applied Therapeutics shares in Q4 2024, an estimated $38.1K.
- Simplex Trading first reported a position in Applied Therapeutics in Q4 2020 and held it in 11 quarters.
- Simplex Trading's Applied Therapeutics position peaked at $799K in Q4 2020.
- 119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.
Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.